|
|
|
Volumn 26 Suppl, Issue , 2000, Pages 8-10
|
|
Implications of the United Kingdom Prospective Diabetes Study (UKPDS) results on patient management.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIDIABETIC AGENT;
ANTIHYPERTENSIVE AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
GLYCOSYLATED HEMOGLOBIN;
ARTICLE;
CARDIOVASCULAR DISEASE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DIABETIC DIET;
FEMALE;
HUMAN;
HYPERTENSION;
INTENSIVE CARE;
MALE;
METABOLISM;
METHODOLOGY;
MIDDLE AGED;
MULTIMODALITY CANCER THERAPY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PROSPECTIVE STUDY;
PSYCHOLOGICAL ASPECT;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
RISK FACTOR;
STANDARD;
TREATMENT OUTCOME;
UNITED KINGDOM;
ADRENERGIC BETA-ANTAGONISTS;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
ANTIHYPERTENSIVE AGENTS;
CARDIOVASCULAR DISEASES;
COMBINED MODALITY THERAPY;
DIABETES MELLITUS, TYPE 2;
DIABETIC DIET;
FEMALE;
GREAT BRITAIN;
HEMOGLOBIN A, GLYCOSYLATED;
HUMANS;
HYPERTENSION;
HYPOGLYCEMIC AGENTS;
INTENSIVE CARE;
MALE;
MIDDLE AGED;
PROSPECTIVE STUDIES;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIALS;
RISK FACTORS;
TREATMENT OUTCOME;
|
|
EID: 0034334566
PISSN: 01457217
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (15)
|
|
References (0)
|
